Today, the United States, Australia, India, and Japan are launching a groundbreaking effort to help end cancer as we know it in the Indo-Pacific ...

The biggest decline was among non-Hispanic Black residents. Their cancer death rate dropped from 245.1 to 124, a 49.4% ...

Sherri McFarland, a professor of chemistry and biochemistry at UTA, is the new president of the American Society for ...

Breast surgical oncologist Anouchka Coste, D.O. has joined Holy Cross Medical Group, a multi-specialty physician employed ...

Clinical laboratory lobbying groups are suing the FDA over its plans to more strictly regulate lab-developed tests. For now, ...

Cancer Discovery publishes high-impact articles featuring major advances in research and clinical trials. Topics span the spectrum of cancer research and medicine from the laboratory to the clinic to ...

It’s hard for practicing oncologists to stay on top of the latest clinical data, but good partnerships and clinical decision ...

The American Cancer Society plans to name an interim CEO by the end of the year and conduct a national search for a permanent ...

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“ Innate ” or the “ Company ”) today reported its consolidated financial results for the six months ended June 30, 2024. The consolidated ...

"I worry that the warning labels may intimidate patients who receive this therapy, which may not be entirely founded," ...

Biomarker testing is critical for determining optimal therapy early in the non–small lung cancer (NSCLC) treatment process, ...

Purple Biotech Ltd. ("Purple Biotech" or "the Company") (NASDAQ/TASE: PPBT), a clinical-stage company developing first-in-class therapies that overcome tumor immune evasion and drug resistance, today ...